Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Operating Expenses | 8,500 | 7,092 | 15,750 | 13,187 | 6,218 |
| Operating Income | -8,500 | -7,092 | -15,750 | -13,187 | -6,218 |
| Interest Expense | 474 | 870 | 1,053 | 97 | 0 |
| Other Income | 32 | -8 | 0 | 0 | 0 |
| Pre-tax Income | -8,942 | -7,970 | -16,803 | -13,284 | -6,218 |
| Income Tax | 8 | -3,264 | 22 | -12 | -787 |
| Net Income Continuous | -8,950 | -4,706 | -16,825 | -13,272 | -5,431 |
| Net Income | $-8,950 | $-4,706 | $-16,825 | $-13,272 | $-5,431 |
| EPS Basic Total Ops | N/A | N/A | N/A | N/A | -0.01 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EPS Diluted Total Ops | N/A | N/A | N/A | N/A | -0.01 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EBITDA(a) | $-8,466 | $-7,097 | $-15,746 | $-13,183 | $-6,215 |